Kruse K, Kracht U, Wohlfart K, Kruse U
Klinik für Pädiatrie, Medizinische Universität zu Lübeck, Federal Republic of Germany.
Eur J Pediatr. 1989 Apr;148(6):535-9. doi: 10.1007/BF00441552.
In addition to the well-documented hyporesponsiveness of the kidney, resistance to parathyroid hormone (PTH) has been postulated for bone in pseudohypoparathyroidism type I (PHP). In some of these patients reduced bone density and even frank osteitis fibrosa suggest osteoclastic overactivity. To address the possibility that the skeletal system of patients with PHP may be affected by their increased PTH secretion we measured intact serum PTH and three biochemical markers of bone turnover in a large number of patients with PHP (n = 20). The results were compared with subjects with low (hypoparathyroidism, HP n = 29), normal (controls, n = 31) and high (primary hyperparathyroidism, 1 degree HPT, n = 13) PTH secretion. Both markers of osteoblastic bone formation, alkaline phosphatase activity and osteocalcin concentration in serum, and one index of osteoclastic bone degradation, the urinary hydroxyproline/creatinine ratio (OH-P/Cr), were decreased in HP and increased in 1 degree HPT, whereas only OH-P/Cr was elevated in patients with PHP. Although intact serum PTH was significantly more increased in PHP than in 1 degree HPT, the markers of bone turnover were not significantly different in these two groups, suggesting some bone resistance in the patients with PHP. In these subjects intact serum PTH was elevated even at normocalcaemia during vitamin D treatment with a negative correlation with the respective serum calcium concentration (r = -0.69, P less than 0.001), indicating an elevated set-point for the suppression of their parathyroid glands. OH-P/Cr was negatively related to serum calcium in PHP, it normalized in most patients during normocalcaemia induced by vitamin D treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
除了已被充分证明的肾脏反应性降低外,I型假性甲状旁腺功能减退症(PHP)患者的骨骼对甲状旁腺激素(PTH)也被推测存在抵抗。在其中一些患者中,骨密度降低甚至出现明显的纤维性骨炎,提示破骨细胞活性增强。为了探讨PHP患者的骨骼系统是否可能受到其PTH分泌增加的影响,我们对大量PHP患者(n = 20)测定了血清完整PTH以及三种骨转换生化标志物。将结果与甲状旁腺激素分泌低(甲状旁腺功能减退症,HP,n = 29)、正常(对照组,n = 31)和高(原发性甲状旁腺功能亢进症,1度HPT,n = 13)的受试者进行比较。成骨细胞骨形成的两个标志物,血清碱性磷酸酶活性和骨钙素浓度,以及破骨细胞骨降解的一个指标,尿羟脯氨酸/肌酐比值(OH-P/Cr),在HP患者中降低,在1度HPT患者中升高,而在PHP患者中只有OH-P/Cr升高。尽管PHP患者血清完整PTH的升高幅度明显大于1度HPT患者,但这两组的骨转换标志物并无显著差异,提示PHP患者存在一定的骨抵抗。在这些受试者中,即使在维生素D治疗期间血钙正常时,血清完整PTH也升高,且与各自的血清钙浓度呈负相关(r = -0.69,P < 0.001),表明其甲状旁腺抑制的设定点升高。在PHP患者中,OH-P/Cr与血清钙呈负相关,在维生素D治疗诱导血钙正常期间,大多数患者的该指标恢复正常。(摘要截选至250字)